A randomized, double-blind, placebo controlled study of Hydralazine-ISDN and Metformin in patients with chronic heart
Funder: Novo Nordisk Fonden
Amount: DKK 1,550,000
Funding type: research
Funder scheme: Projektstøtte i klinisk og translationel lægevidenskab
Start date: 2018-01-01
Investigator: Finn Gustafsson
Institution: Department of Cardiology, Rigshospitalet
Funded outputs count: 0
Funder award ID: nnf-grant-43ea5d61b7d07414
OpenAlex ID: G1409397293